Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

19.75
+0.10000.51%
Volume:678.65K
Turnover:13.26M
Market Cap:1.76B
PE:-7.87
High:19.78
Open:19.69
Low:19.17
Close:19.65
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:1.03
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:116.80
PE(LYR):-5.99

Loading ...

Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Jul 14, 2026

Major Issues Report

Form 8-K - Current report
Jul 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2026

Major Issues Report

Form 8-K - Current report
Jun 11, 2026

Major Issues Report

Form 8-K - Current report
Jun 04, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities